Human Performance Research Centre, INSIGHT Research Institute, Faculty of Health, University of Technology Sydney (UTS), Sydney, NSW, Australia.
Caring Futures Institute, College of Nursing and Health Science, Flinders University, Adelaide, SA, Australia.
JCO Oncol Pract. 2024 Sep;20(9):1160-1172. doi: 10.1200/OP.23.00716. Epub 2024 Apr 29.
People with advanced or metastatic cancer and their caregivers may have different care goals and face unique challenges compared with those with early-stage disease or those nearing the end of life. These Multinational Association for Supportive Care in Cancer (MASCC)-ASCO standards and practice recommendations seek to establish consistent provision of quality survivorship care for people affected by advanced or metastatic cancer.
A MASCC-ASCO expert panel was formed. Standards and recommendations relevant to the provision of quality survivorship care for people affected by advanced or metastatic cancer were developed through conducting (1) a systematic review of unmet supportive care needs; (2) a scoping review of cancer survivorship, supportive care, and palliative care frameworks and guidelines; and (3) an international modified Delphi consensus process.
A systematic review involving 81 studies and a scoping review of 17 guidelines and frameworks informed the initial standards and recommendations. Subsequently, 77 experts (including eight people with lived experience) across 33 countries (33% were low- to middle-resource countries) participated in the Delphi study and achieved ≥94.8% agreement for seven standards, (1) Person-Centered Care; (2) Coordinated and Integrated Care; (3) Evidence-Based and Comprehensive Care; (4) Evaluated and Communicated Care; (5) Accessible and Equitable Care; (6) Sustainable and Resourced Care; and (7) Research and Data-Driven Care, and ≥84.2% agreement across 45 practice recommendations.
Standards of survivorship care for people affected by advanced or metastatic cancer are provided. These MASCC-ASCO standards support optimization of health outcomes and care experiences by providing guidance to stakeholders (health care professionals, leaders, and administrators; governments and health ministries; policymakers; advocacy agencies; cancer survivors and caregivers). Practice recommendations may be used to facilitate future research, practice, policy, and advocacy efforts.Additional information is available at www.mascc.org, www.asco.org/standards and www.asco.org/survivorship-guidelines.
与早期疾病或生命末期的患者相比,晚期或转移性癌症患者及其护理人员可能具有不同的护理目标,并面临独特的挑战。这些多国支持癌症生存协会(MASCC)-美国临床肿瘤学会(ASCO)标准和实践建议旨在为受晚期或转移性癌症影响的人群提供一致的优质生存护理。
成立了一个 MASCC-ASCO 专家小组。通过以下方式制定了有关为受晚期或转移性癌症影响的人群提供优质生存护理的标准和建议:(1)对未满足的支持性护理需求进行系统审查;(2)对癌症生存、支持性护理和姑息治疗框架和指南进行范围审查;(3)进行国际改良 Delphi 共识过程。
一项涉及 81 项研究的系统审查和对 17 项指南和框架的范围审查为初始标准和建议提供了信息。随后,来自 33 个国家的 77 名专家(包括 8 名有生活经验的人)参加了 Delphi 研究,对 7 项标准达成了≥94.8%的共识,这些标准包括:(1)以患者为中心的护理;(2)协调和综合护理;(3)基于证据和全面的护理;(4)评估和沟通护理;(5)可及和公平的护理;(6)可持续和有资源保障的护理;(7)研究和数据驱动的护理。对 45 项实践建议的共识度≥84.2%。
提供了针对受晚期或转移性癌症影响的人群的生存护理标准。这些 MASCC-ASCO 标准通过为利益相关者(医疗保健专业人员、领导者和管理人员;政府和卫生部;政策制定者;宣传机构;癌症幸存者和护理人员)提供指导,支持优化健康结果和护理体验。实践建议可用于促进未来的研究、实践、政策和宣传工作。更多信息可在 www.mascc.org、www.asco.org/standards 和 www.asco.org/survivorship-guidelines 上获取。